These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence? Skolarikos A, Chrisofos M, Ferakis N, Papatsoris A, Dellis A, Deliveliotis C. J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773 [Abstract] [Full Text] [Related]
4. Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR. Orsola A, Cecchini L, Raventós CX, Trilla E, Planas J, Landolfi S, de Torres I, Morote J. BJU Int; 2010 Jan; 105(2):202-7. PubMed ID: 19558557 [Abstract] [Full Text] [Related]
6. Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: a single center randomized controlled trial. Del Rosso A, Pace G, Masciovecchio S, Saldutto P, Galatioto GP, Vicentini C. Int J Urol; 2013 Apr; 20(4):399-403. PubMed ID: 23003110 [Abstract] [Full Text] [Related]
12. The value of a second transurethral resection for T1 bladder cancer. Schwaibold HE, Sivalingam S, May F, Hartung R. BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814 [Abstract] [Full Text] [Related]
14. Superficial bladder tumours: recurrence and progression. Mansoor M, Ali S, Fasihuddin Q, Baloch MU. J Coll Physicians Surg Pak; 2011 Mar; 21(3):157-60. PubMed ID: 21419022 [Abstract] [Full Text] [Related]
15. Transuretral resection of the bladder (TURB): analysis of complications using a modified Clavien system in an Italian real life cohort. De Nunzio C, Franco G, Cindolo L, Autorino R, Cicione A, Perdonà S, Falsaperla M, Gacci M, Leonardo C, Damiano R, De Sio M, Tubaro A. Eur J Surg Oncol; 2014 Jan; 40(1):90-5. PubMed ID: 24284200 [Abstract] [Full Text] [Related]
18. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F. Eur Urol; 2010 Aug; 58(2):185-90. PubMed ID: 20303646 [Abstract] [Full Text] [Related]
20. [Therapy and follow-up of superficial bladder cancer in in patients less than 30 years of age]. Erpenbach K, Roth S, Rathert P. Urologe A; 1994 Nov; 33(6):475-8. PubMed ID: 7817442 [Abstract] [Full Text] [Related] Page: [Next] [New Search]